Rallybio Corporation (NASDAQ: RLYB) Stock Information | RedChip

Rallybio Corporation (NASDAQ: RLYB) Listen to this Section


$1.10
-0.0100 ( -0.90% ) 55.6K

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Market Data


Open


$1.10

Previous close


$1.11

Volume


55.6K

Market cap


$45.64M

Day range


$1.10 - $1.13

52 week range


$1.09 - $5.96

Insider Ownership Transactions

Total Amount Purchased: -468,000.00 | $ -514,800.00

Date Type Amount Purchased Purchaser
2024-05-17 Sale -16500.00 Liu Hui
2024-05-17 Sale -16500.00 Soteropoulos Paula
2024-05-17 Sale -16500.00 Nash Christine A
2024-05-17 Sale -16500.00 Hopfner Robert Lorne
2024-05-17 Sale -16500.00 Chung Wendy
2024-05-17 Sale -16500.00 PARMAR KUSH
2024-05-17 Sale -16500.00 HUNT RONALD
2024-05-17 Sale -16500.00 Boudreau Helen M
2024-02-16 Sale -216000.00 MACKAY MARTIN
2024-02-16 Sale -120000.00 Ryder Steven

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 08, 2024
10-q Quarterly Reports 67 Aug 08, 2024
8-k 8K-related 14 Jul 23, 2024
8-k 8K-related 13 May 21, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.